Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akebia Therapeutics (NQ: AKBA )

0.3208 +0.0207 (+6.90%)
Streaming Delayed Price Updated: 2:40 PM EDT, Sep 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 668,348
Open 0.3217
Bid (Size) 0.3208 (61)
Ask (Size) 0.3241 (3)
Prev. Close 0.3001
Today's Range 0.3050 - 0.3286
52wk Range 0.3000 - 3.350
Shares Outstanding 174,537,458
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for... 
Via Benzinga
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
By David Willey, Benzinga 
Via News Direct

Performance

YTD
-86.91%
-86.91%
1 Month
-9.63%
-9.63%
3 Month
-9.15%
-9.15%
6 Month
-55.31%
-55.31%
1 Year
-88.78%
-88.78%

More News

Read More
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
Via TheNewswire.com
Exposures Product Safety
Akebia Therapeutics Return On Capital Employed Insights
Via Benzinga
Akebia's Anemia Drug Disappoints In Mid-Stage COVID-19 Study
Via Benzinga
Akebia Therapeutics: Q2 Earnings Insights
Via Benzinga
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
Via Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
Via Benzinga
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
Via Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
Via Benzinga
REV Stock Moves Amid Revlon Bankruptcy, Short Squeeze Hopes
Via InvestorPlace
U.S Stocks Turn Lower; Dow Tumbles Over 100 Points
Via Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today?
Via InvestorPlace
Why U.S. Stocks Are Trading Higher, Manufacturing Report And More
Via Benzinga
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Akebia Therapeutics And 20 Stocks Moving Premarket
Via Benzinga
Micron, Akebia Therapeutics And 3 Stocks To Watch Heading Into Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Akebia Therapeutics Stock Is Soaring After Hours
Via Benzinga
Aspen Aerogels And 28 Stocks Moving Premarket
Via Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Via Benzinga
Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.